Heim532983 • BOM
add
RPG Life Sciences Limited
Við síðustu lokun
2.189,65 ₹
Dagbil
2.165,00 ₹ - 2.287,45 ₹
Árabil
1.290,30 ₹ - 2.976,70 ₹
Markaðsvirði
37,44 ma. INR
Meðalmagn
1,41 þ.
V/H-hlutf.
53,54
A/V-hlutfall
0,70%
Aðalkauphöll
NSE
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (INR) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 1,72 ma. | 12,13% |
Rekstrarkostnaður | 774,20 m. | 2,16% |
Nettótekjur | 42,00 m. | -83,76% |
Hagnaðarhlutfall | 2,44 | -85,51% |
Hagnaður á hvern hlut | — | — |
EBITDA | 459,20 m. | 23,18% |
Virkt skatthlutfall | 72,17% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (INR) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,26 ma. | 23,53% |
Heildareignir | 5,54 ma. | 20,22% |
Heildarskuldir | 1,75 ma. | 39,55% |
Eigið fé alls | 3,79 ma. | — |
Útistandandi hlutabréf | 16,54 m. | — |
Eiginfjárgengi | 9,54 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 26,93% | — |
Peningaflæði
Breyting á handbæru fé
| (INR) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 42,00 m. | -83,76% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as API; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
Stofnsett
1993
Vefsvæði
Starfsfólk
1.270
